Results 171 to 180 of about 1,313,066 (193)
Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis. [PDF]
Taha HB, Bogoniewski A.
europepmc +1 more source
Erratum: A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus Statement. [PDF]
europepmc +1 more source
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders. [PDF]
Hall S +5 more
europepmc +1 more source
Cerebrospinal Fluid Levels of Neurogranin in Parkinsonian Disorders
Background: CSF concentration of neurogranin has been suggested as a biomarker for synapse dysfunction. Objectives: To investigate CSF neurogranin in parkinsonian disorders compared to controls and Alzheimer's disease and the possible correlations ...
Sara Hall, Oskar Hansson, Yulia Surova
exaly +3 more sources
Dystonia in atypical parkinsonian disorders
Dystonia is common in the classic atypical parkinsonian disorders such as multiple system atrophy, progressive supranuclear palsy and corticobasal degeneration, and to a lesser extent in dementia with Lewy bodies.
Maja Kojović +2 more
exaly +2 more sources
CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders
There is an unmet need for biomarkers for Parkinson's disease (PD) and atypical parkinsonian disorders (APD). α-Synuclein, linked to the pathogenesis of PD, is a promising biomarker candidate in need of further investigation.
Radu Constantinescu, Jamie Toombs
exaly +2 more sources
Parkinsonian disorders such as Parkinson's disease (PD), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD), are a large group of common neurodegenerative diseases.
Radu Constantinescu +2 more
exaly +2 more sources
Proteomic profiling of cerebrospinal fluid in parkinsonian disorders
Parkinson's disease (PD) and atypical parkinsonian disorders (APD), including multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD), are a group of neurodegenerative diseases sharing many similar signs ...
Radu Constantinescu +2 more
exaly +2 more sources

